Back to search

Peptide record

TPDB15804

Antibacterial Anticancer Toxicity standard
7 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB15804
Antibacterial Anticancer Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
dbAMP Peptipedia
standard
No
A 7-aa standard natural multi-activity (Antibacterial, Anticancer, and Toxicity) peptide sequence curated from dbAMP and Peptipedia, with an available 3D structural model.
Sequence
CVWLVVV
Physicochemical Analysis
C40H64N8O8S1
ARNDEQGHIKMFPSTY
V
817.06
5.33
0
0
6
-0
-2.37
3.171
221.43
Mammalian: 1.2 hour Yeast: >20 hour E.coli: >10 hour
5500
673.15
1
Residue Composition
number
0
A
0
R
0
N
0
D
1
C
0
E
0
Q
0
G
0
H
0
I
1
L
0
K
0
M
0
F
0
P
0
S
0
T
1
W
0
Y
4
V
Amino Acid Distribution
A: 0 R: 0 N: 0 D: 0 C: 1 E: 0 Q: 0 G: 0 H: 0 I: 0 L: 1 K: 0 M: 0 F: 0 P: 0 S: 0 T: 0 W: 1 Y: 0 V: 4
Chemical Descriptors
7
C40H64N8O8S1
817.06
5.33
-0
-2.37
3.171
Evidence Records 7 records
Evidence 1 Activity

Activity

MIC
Antibacterial
1.5 µg/mL

Target

S. pneumoniae

Source & Reference

dbAMP

Other

Source Activity Label Source Definition
Antibacterial
dbAMP classified as Antibacterial under the Anti-bacterial function class.
S. aureus USA300 (LAC) (MIC 1.5 ug/ml), S. aureus USA300 (NRS384) (MRSA) (MIC 1.5 ug/ml), S. pneumoniae (MIC 1.5 ug/ml), S. aureus Mu50 (MIC 3 ug/ml), S. aureus SA113 (MIC 3 ug/ml), S. aureus RN4220 (MIC 3 ug/
Evidence 2 Activity

Activity

MIC
Antibacterial
3 µg/mL

Target

Staphylococcus aureus Mu50

Source & Reference

dbAMP

Other

ug/ml), S. aureus USA300 (NRS384) (MRSA) (MIC 1.5 ug/ml), S. pneumoniae (MIC 1.5 ug/ml), S. aureus Mu50 (MIC 3 ug/ml), S. aureus SA113 (MIC 3 ug/ml), S. aureus RN4220 (MIC 3 ug/ml), E. faecium BK463 (MIC 3 u
Evidence 3 Activity

Activity

MIC
Antibacterial
3 µg/mL

Target

Staphylococcus aureus SA113

Source & Reference

dbAMP

Other

384) (MRSA) (MIC 1.5 ug/ml), S. pneumoniae (MIC 1.5 ug/ml), S. aureus Mu50 (MIC 3 ug/ml), S. aureus SA113 (MIC 3 ug/ml), S. aureus RN4220 (MIC 3 ug/ml), E. faecium BK463 (MIC 3 ug/ml) (Anti-VRE), E. faecalis V
Evidence 4 Activity

Activity

MIC
Antibacterial
3 µg/mL

Target

Staphylococcus aureus RN4220

Source & Reference

dbAMP

Other

pneumoniae (MIC 1.5 ug/ml), S. aureus Mu50 (MIC 3 ug/ml), S. aureus SA113 (MIC 3 ug/ml), S. aureus RN4220 (MIC 3 ug/ml), E. faecium BK463 (MIC 3 ug/ml) (Anti-VRE), E. faecalis VRE366 (MIC 12 ug/ml), L. monocyt
Evidence 5 Activity

Activity

MIC
Antibacterial
3 µg/mL

Target

E. faecium BK463

Source & Reference

dbAMP

Other

aureus Mu50 (MIC 3 ug/ml), S. aureus SA113 (MIC 3 ug/ml), S. aureus RN4220 (MIC 3 ug/ml), E. faecium BK463 (MIC 3 ug/ml) (Anti-VRE), E. faecalis VRE366 (MIC 12 ug/ml), L. monocytogenes ATCC19118 (MIC 6 ug/ml),
Evidence 6 Activity

Activity

MIC
Antibacterial
12 µg/mL

Target

Enterococcus faecalis VRE366

Source & Reference

dbAMP

Other

(MIC 3 ug/ml), S. aureus RN4220 (MIC 3 ug/ml), E. faecium BK463 (MIC 3 ug/ml) (Anti-VRE), E. faecalis VRE366 (MIC 12 ug/ml), L. monocytogenes ATCC19118 (MIC 6 ug/ml), B. subtilis 168 (trpC2) (MIC 4 ug/ml), Gram- P
Evidence 7 Activity

Activity

MIC
Antibacterial
6 µg/mL

Target

L. monocytogenes ATCC19118

Source & Reference

dbAMP

Other

C 3 ug/ml), E. faecium BK463 (MIC 3 ug/ml) (Anti-VRE), E. faecalis VRE366 (MIC 12 ug/ml), L. monocytogenes ATCC19118 (MIC 6 ug/ml), B. subtilis 168 (trpC2) (MIC 4 ug/ml), Gram- P-aeruginosa PAO1 (MIC > 50 ug/ml) and E-co